Skip to main content

Deciphera Pharmaceuticals, Inc.

DCPHDelisted Jun 11, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001654151

Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of DCPH: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders1502143−5
Shares49.1M175.4K52.3M+3.32M (+6.8%)
Value$908.4M$3.24M$856.4M−$48.7M (−5.4%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (19)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to DCPH in Q4 2022
InstitutionSharesValue% of portfolio
Braidwell LP3,271,513$53.6M1.80%
Wolverine Trading, LLC1,752,000$28.7M0.49%
Jefferies Financial Group Inc.175,118$2.87M0.05%
Renaissance Technologies LLC90,700$1.49M0.00%
Dana Investment Advisors, Inc.35,439$580.8K0.03%
Campbell & CO Investment Adviser LLC28,217$462.5K0.11%
Mackenzie Financial Corp21,433$351.3K0.00%
Alberta Investment Management Corp20,434$334.9K0.00%
Kula Investments, LLC18,196$298.2K0.11%
Boulder Hill Capital Management LP13,400$219.6K0.18%
American Century Companies Inc11,938$195.7K0.00%
Franklin Resources Inc10,942$179.3K0.00%
Point72 Middle East FZE9,276$152.0K0.01%
Compass Wealth Management LLC4,250$69.7K0.02%
Accurate Wealth Management, LLC73$1.57K0.00%
First Horizon Advisors, Inc.65$1.06K0.00%
Tfo-TDC, LLC30$7950.00%
Romano Brothers and Company15$2460.00%
Covestor Ltd7$00.00%

Sold out (24)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (2)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DCPH in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Jefferies Group LLC175,148$3.24M
Wipfli Financial Advisors LLC,204$4.00K